|
| Exchange Disseminated Time | Shilpa Medicare Ltd has informed BSE that The Company's State of art facility at Pharma Park Jadcherla (SEZ), near Mahaboobnagar (AP) for undertaking "Contract Research & Forward Integration i.e. Own Formulation" (Manufacturing of Oral & Injectible (Onco Products) has started functioning partially.
Facility for manufacture of Formulation section will commence commercial production in stages after successful completion of trial production/stability tests etc. which is underway.
The Company had visualized Contract Research as one of the thrust area few years back. It invested in creating Research & Development Centre's at two places. Such investment has started yielding results. It expects that this will grow in time to come and would become an important source of income, besides inventing new/improved products for the Company. |
|
|